NDC11 45963061556
This exact 11-digit normalized identifier can correspond to more than one FDA hyphenation. FDA.report preserves the exact identifier and exposes every structurally valid candidate without guessing.
Possible FDA NDC forms#
| Package NDC | Product root |
|---|---|
| 45963-0615-56 | 45963-0615 |
| 45963-615-56 | 45963-615 |
openFDA label cross-check#
OpenFDA label data provides additional search and identifier links. DailyMed’s Structured Product Label is the canonical label on FDA.report. Matching records are deduplicated before they are shown below.
| Brand | Generic | Manufacturer | SPL set ID | Effective date | Available safety fields | Join |
|---|---|---|---|---|---|---|
| Topotecan hydrochloride | TOPOTECAN HYDROCHLORIDE | Actavis Pharma, Inc. | 996430c0-ee26-4ed9-82b8-a8b645becba6 | 2022-08-31 | Boxed warning, Warnings, Adverse reactions | 45963-615-56 45963-615 45963061556 |
Reported adverse events (FAERS/openFDA)#
Adverse event summaries are temporarily unavailable. Other product information remains available.